Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Brar

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Lancet (London, England)|April 7, 2022
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trialFelix Mahfoud, David E Kandzari, Kazuomi Kario, et al.
BMC Nephrology|July 30, 2021
Achieved blood pressure post-acute kidney injury and risk of adverse outcomes after AKI: A prospective parallel cohort studyIan McCoy, Sandeep Brar, Kathleen D Liu, et al.
European Heart Journal|November 18, 2014
Predictors of blood pressure response in the SYMPLICITY HTN-3 trialDavid E Kandzari, Deepak L Bhatt, Sandeep Brar, et al.
Journal of the American College of Cardiology|November 1, 2023
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E Kandzari, Raymond R Townsend, Kazuomi Kario, et al.
Lancet (London, England)|April 3, 2020
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trialMichael Böhm, Kazuomi Kario, David E Kandzari, et al.
The New England Journal of Medicine|February 13, 2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding RiskStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Lancet (London, England)|April 7, 2022
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trialFelix Mahfoud, David E Kandzari, Kazuomi Kario, et al.
BMC Nephrology|July 30, 2021
Achieved blood pressure post-acute kidney injury and risk of adverse outcomes after AKI: A prospective parallel cohort studyIan McCoy, Sandeep Brar, Kathleen D Liu, et al.
European Heart Journal|November 18, 2014
Predictors of blood pressure response in the SYMPLICITY HTN-3 trialDavid E Kandzari, Deepak L Bhatt, Sandeep Brar, et al.
Journal of the American College of Cardiology|November 1, 2023
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E Kandzari, Raymond R Townsend, Kazuomi Kario, et al.
Lancet (London, England)|April 3, 2020
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trialMichael Böhm, Kazuomi Kario, David E Kandzari, et al.
The New England Journal of Medicine|February 13, 2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding RiskStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
Pageof 5